Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Christopher Niyibizi"'
Publikováno v:
Journal of Bone and Mineral Metabolism. 37:773-779
Mutations in Serpinf1 gene which encodes pigment epithelium-derived factor (PEDF) lead to osteogenesis imperfecta type VI whose hallmark is defective matrix mineralization. We reported previously that PEDF reduced expression and synthesis of Sost/Scl
Publikováno v:
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1864:3449-3458
Mutations in Serpinf1 gene which encodes pigment epithelium derived factor (PEDF) lead to osteogenesis imperfecta type VI whose hallmark is defective mineralization. We reported that PEDF suppressed expression of Sost/Sclerostin and other osteocyte r
Publikováno v:
Biochemical and Biophysical Research Communications. 478:1106-1110
Pigment epithelium-derived factor (PEDF) encoded by serpinf1 is a potent anti-angiogenic factor found in a wide variety of fetal and adult tissues. Several reports have shown that lack of PEDF leads to osteogenesis imperfecta (OI) type VI whose hallm
Autor:
Feng Li, Christopher Niyibizi
Publikováno v:
Cells Tissues Organs. 201:14-25
Introduction: Cell therapies for generalized musculoskeletal diseases would require distribution of cells to all the skeletal tissues; however, there are controversies regarding the transplantability of multipotent mesenchymal stems cells (MSCs). We
Publikováno v:
Journal of Cellular Physiology. 230:1243-1249
Mutations in Serpinf1 gene which encodes pigment epithelium derived factor (PEDF) lead to osteogenesis imperfecta type VI whose hallmark is defective mineralization. Mechanisms by which PEDF regulates matrix mineralization remain unknown. We examined
Publikováno v:
Stem Cells. 31:2714-2723
Pigment epithelium-derived factor (PEDF) is a potent antiangiogenic factor found in a wide variety of tissues. Recent findings indicated that lack of PEDF leads to osteogenesis imperfecta type VI whose hallmark is a defect in mineralization. We inves
Publikováno v:
Bone. 47:546-555
Currently, there are conflicting data in literature regarding contribution of bone marrow stromal cells (BMSCs) to bone formation when the cells are systemically delivered in recipient animals. To understand if BMSCs contribute to bone cell phenotype
Publikováno v:
Journal of Cellular Biochemistry. 109:643-652
Induced pluripotent stem cells (iPSCs) have generated hope and excitement because of the potential they possess for generating patient-specific embryonic-like stem cells (ESCs). Although many hurdles remain to be solved before the cells can be applie
Publikováno v:
The Open Stem Cell Journal. 1:54-61
Mesenchymal stem cells have generated much interest because of their potential use in regenerative medicine. The major draw back in the application of these cells is that there is no single marker or markers that have been established to identify and
Autor:
Christopher Niyibizi, Feng Li
Publikováno v:
International Journal of Clinical Rheumatology. 4:57-66
Osteogenesis imperfecta (OI) is a brittle-bone disease whose hallmark is bone fragility. Since the disease is genetic, there is currently no available cure. Several pharmacological agents have been tried with not much success, except the recent use o